| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |